22-532 Phase I
A Phase 1, Safety Lead-in and Randomized, Open-label, Perioperative Study of Vorasidenib in Combination with Pembrolizumab in Subjects with Recurrent or Progressive Enhancing IDH-1 Mutant Astrocytomas
Search Cancer Clinical Trials
Mass General Brigham Cancer Institute offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
14 results
24-580 Phase II
A phase 2 randomized open-label pilot study of Granulocyte Colony Stimulating Factor (G-CSF) to preserve brain structure and function following standard chemoradiation in patients with newly diagnosed MGMT-methylated glioblastoma
23-225 Phase II
A Phase 2, multicenter, open label, two parts clinical study to evaluate the efficacy and safety of safusidenib erbumine in patients with isocitrate dehydrogenase 1 (IDH1) mutant glioma
24-215 Phase III
A Phase 3 Study of Sodium Thiosulfate for Reduction of Cisplatin-Induced Ototoxicity in Children with Average-Risk Medulloblastoma and Reduced Therapy in Children with Medulloblastoma with Low-Risk Features
18-018 Phase I
A Phase I, Multicenter Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending Doses of AZD1390 in Combination with Radiation Therapy in Patients with Glioblastoma Multiforme and Brain Metastases from Solid Tumors
24-575 Phase I
A Phase I, Open-Label, Multicenter, Dose Escalation and Expansion Study of HM16390 in Patients with Advanced or Metastatic Solid Tumors
24-339 N/A
A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
15-715 Phase II
A071401: Phase II Trial of SMO/AKT/NF2/CDK Inhibitors in Progressive Meningiomas with SMO/AKT/NF2/CDK Mutations
19-429 Phase III
Glioblastoma Adaptive, Global, Innovative Learning Environment (GBM AGILE)
22-175 Phase I
INCIPIENT: INtraventricular CARv3-TEAM-E T Cells for PatIENTs with GBM
Showing 1 - 10 of 14 results